APA
Tse B. W. C., Volpert M., Ratther E., Stylianou N., Nouri M., McGowan K., Lehman M. L., McPherson S. J., Roshan-Moniri M., Butler M. S., Caradec J., Gregory-Evans C. Y., McGovern J., Das R., Takhar M., Erho N., Alshalafa M., Davicioni E., Schaeffer E. M., Jenkins R. B., Ross A. E., Karnes R. J., Den R. B., Fazli L., Gregory P. A., Gleave M. E., Williams E. D., Rennie P. S., Buttyan R., Gunter J. H., Selth L. A., Russell P. J., Nelson C. C. & Hollier B. G. (20170918). Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene.
Chicago
Tse B W C, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman M L, McPherson S J, Roshan-Moniri M, Butler M S, Caradec J, Gregory-Evans C Y, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer E M, Jenkins R B, Ross A E, Karnes R J, Den R B, Fazli L, Gregory P A, Gleave M E, Williams E D, Rennie P S, Buttyan R, Gunter J H, Selth L A, Russell P J, Nelson C C and Hollier B G. 20170918. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene.
Harvard
Tse B. W. C., Volpert M., Ratther E., Stylianou N., Nouri M., McGowan K., Lehman M. L., McPherson S. J., Roshan-Moniri M., Butler M. S., Caradec J., Gregory-Evans C. Y., McGovern J., Das R., Takhar M., Erho N., Alshalafa M., Davicioni E., Schaeffer E. M., Jenkins R. B., Ross A. E., Karnes R. J., Den R. B., Fazli L., Gregory P. A., Gleave M. E., Williams E. D., Rennie P. S., Buttyan R., Gunter J. H., Selth L. A., Russell P. J., Nelson C. C. and Hollier B. G. (20170918). Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene.
MLA
Tse B W C, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman M L, McPherson S J, Roshan-Moniri M, Butler M S, Caradec J, Gregory-Evans C Y, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer E M, Jenkins R B, Ross A E, Karnes R J, Den R B, Fazli L, Gregory P A, Gleave M E, Williams E D, Rennie P S, Buttyan R, Gunter J H, Selth L A, Russell P J, Nelson C C and Hollier B G. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. : Oncogene. 20170918.